Table 2.

Donor HCV Characteristics and Recipient HCV Status Post-transplant.

Donor Recipient Pair	Donor			Recipient
	GTa	HCV RNA	HCV Ab	HCV RNA				HCV Ab FW12	+PPse
				POD1b	TW1c	TW12	FWd12		Baseline	FW8
1	NDf	467	+	<15	<15	<15	<15	−	0	0
2	NDf	104	+	<15	<15	<15	<15	+	0	0
3h	NDf	<15	+	<15	<15	<15	<15	−	2	1
4	1a/3	46,733	+	<15g	<15	<15	<15	−	0	0
5h	1a	62,400	+	<15	<15	<15	<15	+	4	8
6	1a	4,645,289	+	94	<15	<15	<15	−	1	0
7	3	2,090,042	+	<15g	<15	<15	<15	+	0	0
8	2	1,760,000	+	136	55	<15	<15	+	5	2
9	ND	131	+	<15	<15	<15	<15	−	3	6
10	1a	1,140,000	+	32	<15	<15	<15	+	1	2

^aGT Genotype

^bPOD1 Post-operative day 1

^cTW Treatment week

^dFW Follow-up week

^e+PP Positive peptide pools

^fND Not Determined due to insufficient viral RNA

^gTarget detected, not quantifiable

^hDonor received significant blood products and specimen for testing may have been hemodiluted.